Phase 2 single-arm study on the efficacy and safety of niraparib in japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Tsutomu Tabata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji SuminoJunpei Soeda, Ajit Suri, Daisuke Aoki, Toru Sugiyama

研究成果: Article › 査読

4 被引用数 (Scopus)

フィンガープリント

「Phase 2 single-arm study on the efficacy and safety of niraparib in japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences